Investment Information

With transparent disclosure of information and communication with markets,
we will grow along with shareholders.

Disclosures & Reports

Public Disclosures

NO Title Date Submission Obligator
10 Organization of Investor Relations Event 2019/10/31 HANALL BIOPHARMA CO.,LTD
9 Interim Report on Business Performance(Fair Disclosure) 2019/10/28 HANALL BIOPHARMA CO.,LTD
8 Organization of Investor Relations Event 2019/09/03 HANALL BIOPHARMA CO.,LTD
7 Organization of Investor Relations Event 2019/08/26 HANALL BIOPHARMA CO.,LTD
6 Implementation and Operation of Compliance Program of the Fair Trade Commission 2019/08/22 HANALL BIOPHARMA CO.,LTD
5 [Investment Caution]small number of branches being focused on 2019/08/07 HANALL BIOPHARMA CO.,LTD
4 Designation of overheated short-selling issues (applied by a restriction on short-selling) 2019/08/05 HANALL BIOPHARMA CO.,LTD
3 Interim Report on Business Performance(Fair Disclosure) 2019/07/30 HANALL BIOPHARMA CO.,LTD
2 Organization of Investor Relations Event 2019/06/05 HANALL BIOPHARMA CO.,LTD
1 Organization of Investor Relations Event 2019/05/14 HANALL BIOPHARMA CO.,LTD

Electronic Announcement

공시정보 전자공고 목록
NO Title Date Related Data
2 2018 Statement of financial position 2019-03-22
1 2017 Statement of financial position 2018-03-30

Management Regulation on Public Announcement

공시정보 전자공고 목록
NO Title Date Related Data
1 Management Regulation on Public Announcement 2009-08-31